VRTX
Common StockVERTEX PHARMACEUTICALS INC / MA
Reported Shares
132.9K
Position Mix
No options reported
Reported Value
$69.5M
Portfolio Weight
13.73%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$506.1M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
VRTX
Common StockVERTEX PHARMACEUTICALS INC / MA
Reported Shares
132.9K
Position Mix
No options reported
Reported Value
$69.5M
Portfolio Weight
13.73%
LLY
Common StockELI LILLY & Co
Reported Shares
51K
Position Mix
No options reported
Reported Value
$59.0M
Portfolio Weight
11.66%
TEVA
Depositary ReceiptTEVA PHARMACEUTICAL INDUSTRIES LTD
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$48.5M
Portfolio Weight
9.57%
AMRX
Common StockAmneal Pharmaceuticals, Inc.
Reported Shares
2.3M
Position Mix
No options reported
Reported Value
$46.9M
Portfolio Weight
9.26%
DXCM
Common StockDEXCOM INC
Reported Shares
489.4K
Position Mix
No options reported
Reported Value
$42.2M
Portfolio Weight
8.34%
JAZZ
Common StockJazz Pharmaceuticals plc
Reported Shares
160.3K
Position Mix
No options reported
Reported Value
$37.1M
Portfolio Weight
7.33%
ARGX
Depositary ReceiptARGENX SE
Reported Shares
30.4K
Position Mix
No options reported
Reported Value
$29.1M
Portfolio Weight
5.76%
ASND
Common StockAscendis Pharma A/S
Reported Shares
118.4K
Position Mix
No options reported
Reported Value
$27.0M
Portfolio Weight
5.33%
AXSM
Common StockAxsome Therapeutics, Inc.
Reported Shares
143.3K
Position Mix
No options reported
Reported Value
$26.4M
Portfolio Weight
5.22%
JNJ
Common StockJOHNSON & JOHNSON
Reported Shares
73.6K
Position Mix
No options reported
Reported Value
$19.5M
Portfolio Weight
3.85%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
410.2K
Position Mix
No options reported
Reported Value
$18.8M
Portfolio Weight
3.72%
UTHR
Common StockUNITED THERAPEUTICS Corp
Reported Shares
33K
Position Mix
No options reported
Reported Value
$17.9M
Portfolio Weight
3.53%
MDGL
Common StockMADRIGAL PHARMACEUTICALS, INC.
Reported Shares
33.7K
Position Mix
No options reported
Reported Value
$17.0M
Portfolio Weight
3.35%
CELC
Common StockCelcuity Inc.
Reported Shares
202.6K
Position Mix
No options reported
Reported Value
$16.1M
Portfolio Weight
3.18%
DNTH
Common StockDianthus Therapeutics, Inc. /DE/
Reported Shares
177.2K
Position Mix
No options reported
Reported Value
$15.6M
Portfolio Weight
3.08%
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
40K
Position Mix
No options reported
Reported Value
$8.2M
Portfolio Weight
1.62%
DFTX
Common StockDefinium Therapeutics, Inc.
Reported Shares
144.4K
Position Mix
No options reported
Reported Value
$5.5M
Portfolio Weight
1.09%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
90.1K
Position Mix
No options reported
Reported Value
$1.9M
Portfolio Weight
0.37%